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Decision-makinga b s t r a c t
Mothers are often responsible for vaccination decisions in the household. However, their confidence in
certain vaccines such as Human Papillomavirus (HPV) vaccines is eroding in some countries. France is
one of the countries with the lowest HPV vaccine uptake in Europe, with parents delaying or refusing
the vaccine for their adolescent daughters due to safety- and effectiveness-related concerns. Although
parental consent is required for vaccination, adolescents’ involvement in HPV vaccination decision-
making could improve vaccine uptake, with self-consent procedures already introduced in some coun-
tries. Adolescents’ capacity to engage in decision-making is influenced by their maturity and autonomy
in health. This study explored the role of maturity in decision-making around HPV vaccination in France
through qualitative interviews with adolescent girls (n = 24) and their mothers (n = 21) and two focus
groups with adolescent girls (n = 12). A codebook approach to thematic analysis revealed that adolescent
girls’ involvement in HPV decision-making is a process that evolved with maturity. As adolescents pro-
gressed towards maturity at different speeds, some expressed childlike traits such as impulsive decisions
and others described more rational, reflective decision-making. Despite these differences, most adoles-
cents in this study described a passive role in HPV vaccination decision-making, following their parents’
lead. However, their expressed desire for information and involvement in discussions indicates that their
lack of engagement may not only be due to a lack of maturity but also a result of mothers and doctors
excluding them from getting involved. Furthermore, as health behaviours are shaped during adolescence,
the influence of vaccine hesitant mothers on their daughters’ own views and beliefs could be significant,
together with exposure to regular controversies in the mainstream media. Individualised approaches to
engage adolescents in decision-making around their own health are needed, for example through
strengthening discussions and information around HPV vaccination with parents and doctors.
 2021 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Mothers across the world, play a caregiving and protective role
for children and are primarily responsible for household health-
related decisions [1,2]. As family health managers, they play a
key role in teaching children healthy behaviours such as nutrition,
hygiene and vaccination, with children commonly assuming the
behaviours, beliefs and values of their mothers [2–4].Some mothers delay or refuse vaccination for their children,
questioning the necessity, effectiveness and safety of vaccines
[5,6]. Increasing exposure to unverified and often negative infor-
mation on the internet and social media, together with contextual
and historical factors such as poor government management of
previous health crises, including lack of transparency breeding dis-
trust, have contributed to the decrease of public confidence in vac-
cination in some communities [7,8]. In some cases, this has led to
important drops in vaccination coverage rates and the resurgence
of vaccine-preventable diseases, as observed in recent measles out-
breaks [9,10].
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vaccination
Vaccination against human papillomavirus (HPV) has elicited
particularly strong concerns among parents, in part due to wide-
spread controversies around the vaccine’s safety that circulated
in some countries [11,12]. France has one of the lowest HPV vacci-
nation rates within Europe, with parents citing concerns about
possible side effects and insufficient protection provided by the
vaccine as reasons for refusal [13–16].
Compared to many countries in which HPV vaccination is
administered in schools, the vaccine is administered by family doc-
tors in France, targeting 11 to 14 year old girls as well as 15 to
19 year old girls as part of a catch-up campaign [17]. While there
is no international agreement on the age at which adolescents
are considered to be competent to make medical decisions, includ-
ing vaccination, legal majority is often used as a threshold in Euro-
pean countries [18]. Minors under 18 years old in France are
unable to be vaccinated against HPV without their parents’ con-
sent, which is often given implicitly [17]. Yet, studies have shown
that adolescents as young as 11 years old could be competent to
make informed decisions, including participation in clinical trials
and acceptance of medical treatments [18–20]. While adolescents’
competence is task and context specific, adolescents in some coun-
tries are increasingly being given a more active role in providing
their consent to receive HPV vaccination. In the United Kingdom,
the Gillick competency tool is used by health professionals to
assess the competency of adolescents to provide consent for vacci-
nation [21,22]. This allows adolescents to be vaccinated even if
their parents have not provided written consent, whether for logis-
tical or for ideological reasons [21,22].
However, involving adolescents in vaccination decision-making
could include various challenges. Adolescents’ competency to
make health decisions depends on a variety of factors, including
their maturity level and ability and readiness to assume responsi-
bility for health and life decisions over time.
1.2. The role of maturity in adolescent decision-making
Maturity is defined differently across legal, social, psychologi-
cal, sexual or public health contexts. In this paper, we use Cauff-
man and Steinberg’s definition of maturity, in relation to
judgement in decision-making [23]. While their definition was
proposed in the context of legal decisions, it has previously been
applied to health [24,25] and refers to essential factors influencing
vaccine decision-making. They define maturity of judgment in
decision-making in relation to three key psychosocial factors:
responsibility, temperance and perspective [23]. Responsibility
refers to the development of a sense of personal identity, leading
to health autonomy and the ability to make decisions indepen-
dently, resisting external pressure to act in a way that may go
against one’s own values [23]. Rather than simply disregarding
the advice of others, it is about understanding how others can
influence one’s own beliefs and behaviour and knowing where
and when to turn for advice [23,26]. Temperance is the ability to
control one’s emotions and impulses, avoiding rash decisions and
evaluating situations before making a rational and informed deci-
sion [18,23,26,27]. Perspective is the acknowledgement of the big-
ger context in which decisions are made, for example by
understanding short- and long-term consequences of decisions or
by being able to see how one’s decision may affect others
[18,23,28]. It also refers to the understanding of why others make
certain decisions and the influence of larger forces that cannot
always be controlled such as the role of social institutions [23].
These factors can define how adolescents make decisions,
including around HPV vaccination, although they will also depend5742on the nature of the situation and the context in which a decision is
being made [18,23]. Maturity should be understood as a contin-
uum rather than a binary concept, which means that children of
the same age may have different levels of maturity as they progress
differently through physical, neurodevelopmental, psychological
and social changes [23,29]. Furthermore, while adolescents may
be mature enough to make decisions in certain areas, they could
be less competent in others [18]. Intellectual maturity may not
automatically imply emotional or social maturity; for instance,
while adolescents may understand medical information, they have
been shown to be more likely than adults to be influenced by their
emotions when making decisions [18,26]. The age at which HPV
vaccination is given in France corresponds to major life and social
changes and school transitions, as adolescents move from primary
school (ages 6–11) to middle school (ages 11–15). The impact of
this transitional period between childhood and adulthood is not
negligible, as adolescents reach an age when they seek greater
independence from parents while experiencing closer relations
with peers, which could have important implications for health
decision-making [30].
1.3. Aim and rationale
In this paper, we explore the role of maturity in adolescents’
involvement in the decision-making process about being vacci-
nated against HPV in France. This understanding can provide
insights into adolescents’ interactions with their mothers during
the decision-making process as well as insights on how mothers’
concerns about vaccination could shape their daughters’ current
and future beliefs and perceptions of vaccination. These findings
could provide valuable information for the development of policies
on adolescent consent for vaccination.2. Methods
Qualitative semi-structured interviews and focus group discus-
sions with adolescent girls and their mothers were conducted in
France to explore the role of maturity in decision-making around
HPV vaccination.
2.1. Data collection
Between October 2018 and March 2019, 24 in-depth interviews
and two focus groups (with 5 and 7 participants in each group)
were conducted with adolescent girls (aged 15–16) and 21 in-
depth interviews were conducted with their mothers. Participants
were purposively selected to include both vaccinated and unvacci-
nated girls from different districts in Paris. However, only eight
vaccinated girls were identified for this study, three of whom took
part in focus group discussions.
Participants were identified using two recruitment methods.
Adolescents were first approached through public, private and pro-
fessional Lycées (high schools), with prior approval from the school
directors. However, as only four interviews and two focus groups
were conducted using this recruitment method, a local research
agency specialised in behavioural research (BVA Group) was con-
tracted to identify additional participants. All participants received
a study information letter that described the study objectives and
stated how interviewees’ confidentiality would be protected. Ado-
lescent girls and their mothers were required to provide written
informed consent to take part in the study. Adolescents were also
asked to obtain written consent from their parents.
Interviews (30–60 min) and focus groups (60 min) were con-
ducted in French by an experienced qualitative researcher who is
fluent in English and French. The interviews were conducted in
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focus groups took place in schools with girls from the same school
class. Interviews and focus group discussions were audio-recorded
with prior approval from all participants. All interviews were con-
ducted privately; no caregiver requested to be present during the
interviews with adolescents. Adolescents recruited through
schools entered a lottery to receive an Amazon voucher to thank
them for their time, while all participants recruited through the
research agency were compensated for their time.
Topic guides for the interviews and focus group discussions (see
supplementary materials) were designed to cover predetermined
questions around HPV vaccination knowledge, decision-making
processes and influences, and beliefs and perceptions, while
remaining sufficiently flexible to allow discussions to be shaped
by the participants’ responses. The topic guides were piloted with
three adolescent girls (excluded from the analysis).2.2. Data analysis
This study used a codebook approach to thematic analysis, as
described by Braun and Clarke as a cluster of methods distinct to
reflective thematic analysis in its use of a structured coding frame-
work [31]. Transcripts from the interviews and focus group discus-
sions, field notes and analytical memos were imported into Nvivo
for analysis. All data files were anonymised to ensure confidential-
ity, removing personal identifiers such as names and locations and
using numerical codes to refer to participants (using the letter ‘V’
to indicate vaccinated individuals). All files were stored on a secure
server and password-protected computers. Analysis was con-
ducted in French to avoid losing the meaning of data, with quotes
for this paper directly translated into English for write-up by the
researcher fluent in both languages.
Data was analysed using a coding framework, developed by
deductively drawing parent codes from the topic guides, existing
literature and contextual background information and the analyti-
cal memos. The coding framework was tested on four transcripts
and finalised using an inductive process to derive additional codes.
The final framework used to code remaining transcripts was
reviewed by a second researcher, allowing some codes to be mod-
ified, merged or removed during the analysis.
Transcripts from interviews with mothers and adolescent girls
and focus groups with adolescent girls were coded separately to
detect differences and similarities in the coding phase. Coded
excerpts as well as the language used by participants was then
compared between mothers and adolescent girls, with particular
attention paid to exchanges between adolescent girls during the
focus group to understand how HPV vaccination is discussed
among peers.
Codes were analysed by inductively drawing a list of issues and
themes from a comparison and analysis of coded excerpts. These
themes were then analysed in the context of literature on adoles-
cent decision-making, following a framework analysis approach to
theme development [32]. This type of analytical approach also
recognises the researchers’ subjectivity in analysis and the contex-
tual aspect of knowledge [31].
Ethical approval
This study obtained ethical approval from the London School of
Hygiene & Tropical Medicine [Ref. 15320 3] and from Aix-Marseille
Université [Ref. 2018–12-07–005].3. Results
HPV vaccination was generally discussed by participants as a
decision that should involve girls and mothers. However, percep-
tions about the extent to which adolescent girls should be included5743in the decision varied widely between and within families. Both
mums and girls spontaneously referred to ‘maturity’, independence
and responsibility as key factors influencing the role adolescents
should have in decision-making: ‘‘It depends on everyone’s maturity,
because some people can be convinced of their decision at a certain
age but (. . .) without necessarily having enough hindsight” (A19)..
While none described what they meant by the term ‘maturity’, dif-
ferences in maturity levels were used to explain why some adoles-
cent girls might be involved in HPV vaccination decision-making
and others may not. The word ‘immature’ was never used and
involvement in decision-making was instead described as a pro-
cess that evolves together with maturity. Some adolescents
described their own process of change and perception of becoming
more mature: ‘‘My mentality also changed a lot in comparison to
before. Now, I ask myself a lot more questions, while before, it was ‘I
have to do it, so I do it’” (A3).
Five key themes were identified through the thematic analysis,
organised and described in further details below according to
Cauffman and Steinberg’s definition of factors influencing matu-
rity. The themes ‘adolescents’ role in decision making, ‘recognising
the influence of others’ and ‘adolescent girls’ understand of HPV
vaccination relate to ‘responsibility’. The theme ‘impulsive and
emotional decisions’ related to temperance, and the theme ‘under-
standing the broader context in which decisions are made’ relates
to ‘perspective’.
3.1. Adolescents’ role in decision making
Adolescent girls’ involvement in HPV vaccination decision-
making was mostly described by mothers in terms of ‘passive obe-
dience’, with one mother explaining that her daughter would hand
over all responsibility to her without understanding what deci-
sions such as vaccination mean (M14). Similar to childhood vacci-
nation, girls followed their parents’ decisions without taking into
consideration their own values or preferences, sometimes without
being aware of which vaccine they received: ‘‘My parents take me
[to get vaccinated] but I don’t know what I’m vaccinated against
(. . .) So, I really don’t know whether I received [the HPV vaccine] or
not” (A2). Some girls not only followed their parents’ decisions,
but repeated the concerns expressed by their mothers, without
always understanding them. Although this was in part explained
as part of a strong relation of trust, girls also thought that their par-
ent’s life experience made them more capable of reflecting on the
decision: ‘‘I think parents’ advice is to be taken into account because
they are adults, they have life experience” (A10). While some girls
explained feeling mature, health was seen as an area remaining
under parental responsibility. A couple of girls preferred to dis-
tance themselves from decisions that could carry possible risks:
‘‘I prefer to let my mum decide for me, because if something happens
to me, I don’t want to be responsible” (A15).
Mothers also discussed HPV vaccination as their responsibility,
sometimes preventing their daughters from taking part in the deci-
sion: ‘‘I did it early to take the decision instead of her, and I assume
that completely; for me it’s the mother’s role.” (M1V). Doctors
seemed to share that perspective, as girls explained they rarely dis-
cussed HPV vaccination directly with them: ‘‘He said ‘on this day, I
would like you to come back to get a vaccine’, but then he explained
everything to my mum” (FG2). One mother believed that involving
her daughter in this decision would represent ‘cowardice’ and not
‘assuming your role as a parent in decision making’, stressing that
‘‘the responsibility could place a weight on her shoulders” (M16).
Despite most girls and mothers agreeing that the decision
should remain the responsibility of parents, some participants
believed that girls should also be involved in the decision to some
extent. Having an informed discussion about the vaccine and HPV
infection and cervical cancer was described as important by both
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vaccine concerns their own bodies, they should make the final
decision, showing a sense of personal identity and separate self:
‘‘It concerns girls, not parents. They won’t be the ones who have to live
with the vaccine, or who have to get vaccinated. Girls, not parents
should decide” (A20). The age for legal maturity and parental con-
sent was also questioned by mothers, who acknowledged that
today’s adolescents are becoming mature earlier and suggested
that new legislation around access to health could reflect these
changes: ‘‘Maybe if there was a legislation to allow girls who would
like to get vaccinated to do it without their parents’ consent. I mean,
for abortions, young people can do it without their parents’ consent.
So, there is a whole procedure that is already in place.” (M24). A cou-
ple of mums also described trying to empower their daughters in
relation to their own health, explaining that HPV vaccination could
be a good opportunity to help them become more mature: ‘‘I try to
make her more independent. Well, it even goes beyond health; it’s
more. . . yes, in terms of autonomy.” (M11).
3.2. Recognizing the influence of others
When reflecting about HPV vaccination, the role and influence
of others in decision-making was discussed differently by adoles-
cent girls, which could indicate different maturity levels. Although
some girls understood the influence others such as friends, experts
or figures publicly discussing vaccination may have on their own
decisions, others referred to themselves as stubborn or not easily
influenced: ‘‘I like to make decisions myself. (. . .) If the advice fits
me, I follow it, if it doesn’t, I don’t follow it. I follow my own mind”
(A3). One girl also reported doing the opposite of what people tell
her, almost describing an act of teenage rebellion: ‘‘Most of the time,
when people tell me something, I do the opposite (. . .) when I want
something, I really want it so even if I listen to what they tell me. . .
(. . .) I’m quite stubborn actually” (A11). Girls who understood the
influence of others often grounded their responses in more reflec-
tion and explained their decisions would depend on whom they
talk to.
3.3. Adolescent girls’ understanding of HPV vaccination
Maturity in decision-making was described by both mothers
and adolescents in relation to the understanding of what HPV vac-
cination represents, with many describing adolescent girls as too
young to be responsible for the decision: ‘‘I don’t think she has per-
spective, well she cannot understand and could refuse because of
opposition [to her parents] or because she doesn’t like injections, or
because she doesn’t understand the importance of this decision”
(M13V). While some participants were aware of the benefits of
protection against cancer or the understanding of the possible risks
associated with vaccination, some mothers also described maturity
in relation to a girl’s awareness of sexual health: ‘‘she isn’t in this
type of thing, and she doesn’t have the consciousness of all these [is-
sues], what is an STI. . . She’s millions miles away from all of this”
(M11). This was only described by one adolescent girl: ‘‘We’re not
going ask a 10 year-old to choose whether she wants to get vaccinated,
because she doesn’t have the maturity to understand what it consists
of. But I think we should talk more to girls, especially as they engage in
sexual intercourse earlier now, so they should be warned before it hap-
pens” (A24).
Many adolescent girls were not aware of HPV vaccination, and
showed limited understanding around HPV infection, cervical can-
cer and HPV vaccination. They often explained this by a lack of
access to information rather than unwillingness to become more
informed. In fact, many girls explained that they would need more
information before being able to decide whether to accept the vac-
cine, showing an understanding of the need to evaluate situations5744before making decisions. Girls not only explained they would do
their own research before making a decision, but also described
an assessment of where to find trustworthy information. The
importance of obtaining advice from others was raised, especially
those with more expertise such as doctors or those with previous
experience with vaccination, such as older sisters.
3.4. Impulsive and emotional decisions
Adolescence was also seen as a period of change, when deci-
sions are sometimes highly volatile. A few girls changed their mind
repeatedly as the interview progressed. One explained that her
responses cannot be seen as certain because adolescent girls
change their minds based on the situations they are in, from one
day to the next: ‘‘Opinions change all the time. (. . .) the fact that
you ask me all these questions, I answer them, but I know, myself, per-
sonally, I really know that it’s probably going to change. Maybe one
day, I will finally have a response” (A3). While for some girls, this
could be a sign of impulsive decision-making, it could also be a sign
of maturity, showing that adolescents take into account different
influences before making decisions: ‘‘If I still don’t want to get vac-
cinated then I won’t do it and if I received information that convinced
me to get vaccinated, then I would do it” (A21V). This can be partic-
ularly difficult in a controversial context, as adolescents explained
they received conflicting advice from doctors and mothers
described the vaccine as highly controversial.
In comparison to mothers, girls seemed calmer when discussing
HPV vaccination, less influenced by emotions and impulses. While
mothers showed strong fears about the safety of HPV vaccination
and discussed the vaccine as highly controversial, girls were con-
vinced of the protection offered by the vaccine, expressing positive
feelings of security, reassurance and tranquillity associated with a
vaccine that prevents cancer. Girls also explained that as they
become more mature, they have less emotional reactions to deci-
sions. For example, not being afraid of needles was associated with
‘growing up’, with most girls describing their experience of vaccina-
tion as a stress-free one.
3.5. Understanding the broader context in which decisions are made
HPV vaccination was discussed in the context of the general
public’s decisions around vaccination with girls describing public
controversies around vaccination: ‘‘It’s controversial. Of course! If
it wasn’t, we would have done, or we wouldn’t have. . . but we would
be asking ourselves the questions, we wouldn’t be here to talk about it.
I think that’s what differentiate it from other vaccines, yes” (A10).
However, attitudes towards parents who might be hesitant to vac-
cinate their children were varied. Some girls expressed incompre-
hension and strong criticism of parents who might not want to
vaccinate their daughters and protect them against diseases: ‘‘If
parents don’t want her to get vaccinated, it’s not normal” (A23V).
Others, despite disagreeing with anti-vaccine views, expressed an
understanding of the reasons for their hesitancy: ‘‘I know there
are controversies around vaccines, saying that they don’t necessarily
work or they cause other diseases or complications, or that we would
catch the diseases when receiving the vaccine, but I do not believe all
of this” (A24). Finally, some girls, especially those with mothers
with anti-vaccination views, expressed worries about the contro-
versies around HPV vaccination.
Adolescent girls discussed HPV vaccination with both a short-
and long-term outlook, particularly in relation to the prevention
of HPV infection and cervical cancer. In fact, while most girls
described the importance of the prevention of cancer in the long-
term, some girls also believed that it was too early for them to
get vaccinated as they were not sexually active yet: ‘‘If you don’t
have sex when you’re 15 years old, well, I don’t see why you would
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One girl also discussed the permanence of the decision to accept a
vaccine: ‘‘I think that there is more of a preventive nature in saying no
than if I say yes when, well, once we have said yes, in fact, it’s a little
irreversible. We can’t, we can’t go back, so I would say no” (A10).
A few unvaccinated and vaccinated girls also discussed the act
of vaccinating themselves as a social one and a way of protecting
others, such as their sexual partners or the greater community.
Finally, some adolescent girls also understood the role of social
institutions in their decision, mentioning that vaccines can be
trusted because they are produced by experts and health authori-
ties whose role is to protect populations.4. Discussion
This study explored the role of maturity in adolescent decision-
making around HPV vaccination in France. Adolescent girls’
involvement in decision-making was found to be a process that
evolves together with maturity, with important differences identi-
fied in maturity levels and participation in decision-making from
one family to the next. While some girls described childlike traits
such as doing the opposite of what they are being told or making
impulsive decisions without understanding the role and influence
of others on their own decisions, others reported going through
more rational decision-making processes. These differences could
be a consequence of adolescents progressing towards maturity at
different speeds and could be influenced as well as influence rela-
tionships between adolescents and their mothers [33,34]. In fact,
some adolescents described their life as a period of change,
explaining that as they become more mature, they start asking
more questions and become less emotional when making deci-
sions. For example, while many studies have previously reported
strong fears of needles among adolescents [35–37], participants
in this study reported being less anxious about needles than they
used to be when they were younger, associating overcoming their
fears with progressing towards adulthood.
In contrast to more mature adolescents, some girls described
their decision-making process as highly volatile, explaining that
their decisions would be influenced by the information they
receive and the people they speak to, with some girls even repeat-
edly changing their mind about HPV vaccination during the inter-
view. This could suggest these adolescent girls were less
emotionally mature, making decisions emotionally or impulsively
rather than rationally [23]. However, some mothers expressed
even more emotional reactions to HPV vaccination than their
daughters, confirming the theories that adults often make deci-
sions, including in relation to vaccination, using an intuitive, rapid
and sometimes emotional system rather than a more analytical
one [38,39]. Adolescence is not only a period of change for adoles-
cents themselves but also for their mothers, and the impact of
these changes on the role of emotions in mothers’ decision-
making should be explored further. Adolescents’ volatile decisions
and uncertainty may also reflect the controversial environment in
France where the adolescent girls grew up, surrounded by informa-
tion questioning the safety and value of HPV vaccination, including
from medical sources and the mainstream media [15]. More
research is needed to understand the long-term effect of low public
confidence in vaccination on adolescents’ future views on vaccina-
tion, especially in the current context of misinformation spreading
on social and digital media [40].
In fact, adolescent girls expressed strong, albeit varied, opinions
about vaccine hesitant individuals in France. Some girls in this
research were highly critical of those they labelled as ‘‘anti-
vaccine”, questioning why parents, even their own, would refuse
protecting their children against diseases. Others expressed con-5745cerns and worries about the controversies and uncertainties
around HPV vaccination. More importantly, some adolescent girls
also discussed their own mothers’ hesitancy towards vaccination,
repeating their concerns without necessarily understanding them.
Adolescence is an important stage during which health behaviours
and beliefs develop, often being passed down from parents [2,41].
As future parents and vaccinators, adolescence is the first time girls
are asked to face a decision about vaccination and the influence of
vaccine hesitant mothers could have longer term impacts on the
girls’ future vaccine confidence [4].
Furthermore, most girls in this study described their role in HPV
vaccination decision-making as one of passive obedience. Health,
and more specifically vaccination, was described as being the
responsibility of parents, confirming findings from previous
research [35,42,43]. While some girls wished for more involvement
in decision-making, most of them followed their parents’ decisions.
Our findings suggest that adolescents’ lack of involvement in
decision-making may be related to societal restrictions and social
norms rather than solely a lack of maturity. In fact, girls in the
study explained receiving little information about HPV vaccination,
and being ignored by their doctors who discussed the vaccine
directly with their mothers. Only one mother in this study
described HPV vaccination as an opportunity to start empowering
girls to become more autonomous in health decisions. Similarly,
some mothers preferred to avoid talking about the vaccine with
their daughters because of personal concerns about vaccination
or because of the conviction that girls are too young to be involved
in such decisions. The decision of vaccine hesitant mothers to
exclude girls from discussions about the vaccine were previously
observed in another study in the United States [44]. Girls’ exclu-
sions from decision-making means that any positive views towards
vaccination or desire to protect themselves from cervical cancer
may not influence their mothers’ decisions.
As parental consent constitutes a potential barrier to optimal
vaccination uptake and mothers’ hesitancy towards HPV vaccina-
tion is particularly high in France, engaging adolescent girls in
decision-making could be beneficial to improving HPV vaccine
uptake [15,34,43]. Allowing adolescents to participate in health-
care decisions has not only been shown to make themmore auton-
omous and responsible, but also to help adolescents make better
and more informed decisions about sexual health [44–46]. Addi-
tionally, adolescent girls in this study as well as in others have
reported a desire to become more informed and more involved
in decision-making, while showing a strong interest in HPV and
cervical cancer [42,43,47]. Yet, most of them reported not having
received any information from their teachers at school or from
school nurses about the vaccine. Improving communication and
education strategies targeted at adolescents is therefore essential
to improve their understanding of what vaccination represents
and increase their autonomy in vaccination decision-making, espe-
cially as awareness was found to be particularly low in this study.
Furthermore, as adolescents were found to progress at different
speeds towards maturity, a one-size-fits-all approach to adolescent
involvement in shared decision-making may not be appropriate
and more individualised approaches may be required. In the UK
for instance, adolescent self-consent for HPV vaccination is possi-
ble but healthcare professionals are required to use the Gillick
competency tool to evaluate their ability to understand what vac-
cination involves and their competency to make decisions autono-
mously [48]. Adolescent self-consent comes with important
challenges however, such as the risk of straining family relation-
ships by allowing adolescents to override their vaccine-hesitant
parents and the difficulty healthcare professionals may face in
assessing adolescents’ autonomy [21,34]. This is particularly true
as some parents’ hesitancy in France comes from controversies
that surrounded the Hepatitis B vaccination campaign, previously
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cents in their own care and encouraging the development of their
responsibility and autonomy instead may be more appropriate in
countries without self-consent legislation already in place [34].4.1. Study limitations
This study provides a valuable analysis of the role of maturity in
adolescent decision-making around HPV vaccination. However,
some results have to be interpreted with caution. As this was an
exploratory study, maturity was not measured against any tools
and findings focused on thematic analysis instead. Further research
could explore associations between maturity levels, assessed
through such scales, and willingness to accept HPV vaccines. All
adolescent girls included in this study were from Paris, and most
of them were not vaccinated against HPV, which could have
skewed some of the findings. Data was collected with 15 to
16 years old girls, to obtain a sample of girls who had passed the
age of being offered the vaccine. While our findings around matu-
rity may not apply to younger girls, they provide important infor-
mation around the possible involvement of older girls in decision-
making. The use of two different recruitment methodologies may
also have influenced the final sample of participants included in
the study. Girls who accepted to take part in the study may have
been more mature than those who refused, influencing some of
the findings. Findings from this study are only applicable to adoles-
cent girls: no interviews were conducted with adolescent boys as
they were included in the HPV vaccination programme in France
in 2020, after data for this study was collected. Future research
could explore the differences in the role of maturity among boys
and girls in HPV vaccination decision-making.4.2. Conclusion
This study found that adolescent girls in France were rarely
included in HPV vaccination decision-making, despite their inter-
est in HPV and cervical cancer and their desire to be involved in
discussions with their mothers and doctors. While adolescent girls
and mothers described involvement in decision-making as a pro-
cess that evolves together with maturity, adolescents were often
prevented from taking part in decisions by their mothers, doctors,
and a lack of information. As some adolescents showed signs of
maturity of decision-making, strategies should be developed to
increase their gradual engagement in their own care, including in
vaccination. This is especially important in a context where moth-
ers are refusing or delaying HPV vaccination due to low confidence
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